Anti-TNF treatment and renal cell carcinoma in patients with inflammatory bowel disease, rheumatoid arthritis and spondyloarthropathy: trigger or cure?

被引：0
|
作者：
Wauters, L. [1 ]
Joniau, S. [2 ]
Verschueren, P. [3 ]
Van Assche, G. [1 ]
Vermeire, S. [1 ]
Ferrante, M. [1 ]
机构：
[1] Univ Hosp Leuven, Leuven, Belgium
[2] Univ Hosp Leuven, Dept Urol, Leuven, Belgium
[3] Univ Hosp Leuven, Dept Rheumatol, Leuven, Belgium
来源：
JOURNAL OF CROHNS & COLITIS | 2015年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P628
引用
收藏
页码：S395 / S396
页数：2
相关论文
共 50 条
  • [41] Anti-TNF therapy for rheumatoid arthritis and other inflammatory diseases
    Taylor, PC
    MOLECULAR BIOTECHNOLOGY, 2001, 19 (02) : 153 - 168
  • [42] Predictors of neutropaenia on anti-TNF treatment for rheumatoid arthritis
    Rajakulendran, S.
    Gadsby, K.
    Allen, D.
    O'Reilly, S.
    Deighton, C.
    RHEUMATOLOGY, 2006, 45 : I48 - I49
  • [43] Benefit of anti-TNFα treatment for nephrotic syndrome in a patient with juvenile inflammatory bowel disease associated spondyloarthropathy complicated with amyloidosis and glomerulonephritis
    Verschueren, P
    Lensen, F
    Lerut, E
    Claes, K
    De Vos, R
    Van Damme, B
    Westhovens, R
    ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 (04) : 368 - 369
  • [44] Inflammatory bowel disease: anti-TNF strategies and beyond
    Hoffmann, JC
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2004, 129 : S76 - S78
  • [45] Inflammatory bowel disease after anti-TNF drugs
    Hamilton, Louise
    Griffin, Jane
    Dahiya, Sandeep
    Somerville, Margaret
    Stodell, Malcolm
    RHEUMATOLOGY, 2008, 47 : II18 - II18
  • [46] Optimizing anti-TNF treatments in inflammatory bowel disease
    Ben-Horin, Shomron
    Kopylov, Uri
    Chowers, Yehuda
    AUTOIMMUNITY REVIEWS, 2014, 13 (01) : 24 - 30
  • [47] Cost-effectiveness of drug monitoring of anti-TNF therapy in inflammatory bowel disease and rheumatoid arthritis: a systematic review
    Laura Martelli
    Pablo Olivera
    Xavier Roblin
    Alain Attar
    Laurent Peyrin-Biroulet
    Journal of Gastroenterology, 2017, 52 : 19 - 25
  • [48] Loss of response to anti-TNFα agents depends on treatment duration in patients with inflammatory bowel disease
    Schultheiss, Johannes P. D.
    Mahmoud, Remi
    Louwers, Jonas M.
    van der Kaaij, Michiel T.
    van Hellemondt, Boris P.
    van Boeckel, Petra G.
    Mahmmod, Nofel
    Jharap, Bindia
    Fidder, Herma H.
    Oldenburg, Bas
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2021, 54 (10) : 1298 - 1308
  • [49] Cost-effectiveness of drug monitoring of anti-TNF therapy in inflammatory bowel disease and rheumatoid arthritis: a systematic review
    Martelli, Laura
    Olivera, Pablo
    Roblin, Xavier
    Attar, Alain
    Peyrin-Biroulet, Laurent
    JOURNAL OF GASTROENTEROLOGY, 2017, 52 (01) : 19 - 25
  • [50] Serum Levels of Chemerin in Patients with Inflammatory Bowel Disease as an Indicator of Anti-TNF Treatment Efficacy
    Sochal, Marcin
    Fichna, Jakub
    Gabryelska, Agata
    Talar-Wojnarowska, Renata
    Bialasiewicz, Piotr
    Malecka-Wojciesko, Ewa
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (19)
12345